LYB - LyondellBasell Industries N.V.
NYSE
->
Basic Materials
->
Specialty Chemicals
Houston,
United States
Type: Equity
LYB price evolution
LYB
| (in millions $) | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2331 | $3405 | $2844 | $2494 |
| Short term investments | ||||
| Net receivables | $4191 | $3507 | $3841 | $3811 |
| Inventory | $4853 | $4765 | $4911 | $5195 |
| Total current assets | $12875 | $13152 | $13228 | $12693 |
| Long term investments | $3845 | $3907 | $4056 | $4152 |
| Property, plant & equipment | $17013 | $17076 | $16703 | $16972 |
| Goodwill & intangible assets | $2259 | $2288 | $2246 | $2243 |
| Total noncurrent assets | $23749 | $23848 | $23647 | $23990 |
| Total investments | $3845 | $3907 | $4056 | $4152 |
| Total assets | $36624 | $37000 | $36875 | $36683 |
| Current liabilities | ||||
| Accounts payable | $3972 | $3815 | $3574 | $3517 |
| Deferred revenue | ||||
| Short long term debt | $171 | $899 | $893 | $1336 |
| Total current liabilities | $6087 | $7150 | $7000 | $7017 |
| Long term debt | $12403 | $11742 | $11610 | $11713 |
| Total noncurrent liabilities | $17544 | $16906 | $16656 | $16721 |
| Total debt | $12574 | $12641 | $12503 | $13049 |
| Total liabilities | $23631 | $24056 | $23656 | $23738 |
| Shareholders' equity | ||||
| Retained earnings | $9752 | $9692 | $9917 | $9580 |
| Other shareholder equity | -$1532 | -$1476 | -$1400 | -$1333 |
| Total shareholder equity | $12979 | $12930 | $13205 | $12931 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3405 | $2156 | $1477 | $1765 |
| Short term investments | $9 | $702 | ||
| Net receivables | $3507 | $4081 | $4808 | $3441 |
| Inventory | $4765 | $4804 | $4901 | $4344 |
| Total current assets | $13152 | $11845 | $12217 | $11634 |
| Long term investments | $3907 | $4295 | $4786 | $4729 |
| Property, plant & equipment | $17076 | $17112 | $16502 | $15878 |
| Goodwill & intangible assets | $2288 | $2489 | $2570 | $2704 |
| Total noncurrent assets | $23848 | $24520 | $24525 | $23769 |
| Total investments | $3907 | $4295 | $4795 | $5431 |
| Total assets | $37000 | $36365 | $36742 | $35403 |
| Current liabilities | ||||
| Accounts payable | $3815 | $3583 | $4291 | $2948 |
| Deferred revenue | ||||
| Short long term debt | $899 | $781 | $368 | $671 |
| Total current liabilities | $7150 | $6760 | $7230 | $5502 |
| Long term debt | $11742 | $10540 | $12895 | $16508 |
| Total noncurrent liabilities | $16906 | $16976 | $17640 | $21913 |
| Total debt | $12641 | $12831 | $13263 | $17179 |
| Total liabilities | $24056 | $23750 | $24870 | $27415 |
| Shareholders' equity | ||||
| Retained earnings | $9692 | $9195 | $8563 | $4440 |
| Other shareholder equity | -$1476 | -$1372 | -$1803 | -$1943 |
| Total shareholder equity | $12930 | $12615 | $11858 | $7971 |
| (in millions $) | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $9925 | $10625 | $10306 | |
| Cost of revenue | $8763 | $9177 | $8868 | |
| Gross Profit | $1162 | $1448 | $1438 | |
| Operating activities | ||||
| Research & development | $32 | $31 | $32 | |
| Selling, general & administrative | $426 | $378 | $395 | |
| Total operating expenses | $458 | $434 | $427 | |
| Operating income | $704 | $1014 | $1011 | |
| Income from continuing operations | ||||
| EBIT | $722 | $1025 | $1018 | |
| Income tax expense | $122 | $153 | $188 | |
| Interest expense | $127 | $125 | $115 | |
| Net income | ||||
| Net income | $473 | $747 | $715 | |
| Income (for common shares) | $471 | $745 | $714 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $41107 | $50451 | $27753 | |
| Cost of revenue | $35849 | $43847 | $24359 | |
| Gross Profit | $5258 | $6604 | $3394 | |
| Operating activities | ||||
| Research & development | $130 | $124 | $113 | |
| Selling, general & administrative | $1557 | $1310 | $1140 | |
| Total operating expenses | $2205 | $1503 | $1835 | |
| Operating income | $3053 | $5101 | $1559 | |
| Income from continuing operations | ||||
| EBIT | $3099 | $5058 | $1910 | |
| Income tax expense | $501 | $882 | -$43 | |
| Interest expense | $477 | $287 | $526 | |
| Net income | ||||
| Net income | $2121 | $3889 | $1427 | |
| Income (for common shares) | $2114 | $3882 | $1420 | |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | $473 | $185 | $747 | $715 |
| Operating activities | ||||
| Depreciation | $365 | $380 | $367 | $391 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $34 | $20 | $23 | $24 |
| Total cash flows from operations | -$114 | $1504 | $1666 | $1290 |
| Investing activities | ||||
| Capital expenditures | -$483 | -$484 | -$394 | -$301 |
| Investments | $21 | $62 | $2 | |
| Total cash flows from investing | -$510 | -$606 | -$429 | -$371 |
| Financing activities | ||||
| Dividends paid | -$408 | -$406 | -$407 | -$408 |
| Sale and purchase of stock | -$41 | -$100 | ||
| Net borrowings | -$38 | -$425 | $295 | |
| Total cash flows from financing | -$412 | -$405 | -$844 | -$224 |
| Effect of exchange rate | -$38 | $68 | -$43 | -$5 |
| Change in cash and equivalents | -$1074 | $561 | $350 | $690 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $2121 | $3889 | $5617 | $1427 |
| Operating activities | ||||
| Depreciation | $1534 | $1267 | $1393 | $1385 |
| Business acquisitions & disposals | $15 | |||
| Stock-based compensation | $91 | $70 | $66 | $55 |
| Total cash flows from operations | $4942 | $6119 | $7695 | $3404 |
| Investing activities | ||||
| Capital expenditures | -$1531 | -$1890 | -$1959 | -$1947 |
| Investments | $83 | $117 | $578 | -$2891 |
| Total cash flows from investing | -$1777 | -$1977 | -$1502 | -$4906 |
| Financing activities | ||||
| Dividends paid | -$1610 | -$3246 | -$1486 | -$1405 |
| Sale and purchase of stock | -$211 | -$420 | -$463 | -$4 |
| Net borrowings | -$130 | -$4 | -$4374 | $3612 |
| Total cash flows from financing | -$1950 | -$3407 | -$6385 | $2271 |
| Effect of exchange rate | $34 | -$56 | -$96 | $108 |
| Change in cash and equivalents | $1249 | $679 | -$288 | $877 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | -3.14% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.86 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.12 |
| Quick ratio | 1.32 |